Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lehmann

Showing results (401-410 of 410) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 410 results.
Molecular Cell|December 17, 2020
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRDGraeme Hewitt, Valerie Borel, Sandra Segura-Bayona, et al.
European Journal of Neurology|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
The Lancet. Neurology|March 22, 2020
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort studyTim Hagenacker, Claudia D Wurster, René Günther, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 26, 2022
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference valuesSamuel Arends, Judith Drenthen, Peter van den Bergh, et al.
Brain : a Journal of Neurology|September 25, 2018
Regional variation of Guillain-Barré syndromeAlex Y Doets, Christine Verboon, Bianca van den Berg, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Brain : a Journal of Neurology|March 17, 2025
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C M Thomma, Susan K Halstead, Laura C de Koning, et al.
Neurology|August 18, 2022
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 CohortSonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, et al.
Neurology|December 23, 2021
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome ScoreAlex Y Doets, Hester F Lingsma, Christa Walgaard, et al.
Neurology|April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Pageof 41

Showing results (401-410 of 410) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 410 results.
Molecular Cell|December 17, 2020
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRDGraeme Hewitt, Valerie Borel, Sandra Segura-Bayona, et al.
European Journal of Neurology|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
The Lancet. Neurology|March 22, 2020
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort studyTim Hagenacker, Claudia D Wurster, René Günther, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 26, 2022
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference valuesSamuel Arends, Judith Drenthen, Peter van den Bergh, et al.
Brain : a Journal of Neurology|September 25, 2018
Regional variation of Guillain-Barré syndromeAlex Y Doets, Christine Verboon, Bianca van den Berg, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Brain : a Journal of Neurology|March 17, 2025
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndromeRobin C M Thomma, Susan K Halstead, Laura C de Koning, et al.
Neurology|August 18, 2022
An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 CohortSonja E Leonhard, Annemiek A van der Eijk, Henning Andersen, et al.
Neurology|December 23, 2021
Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome ScoreAlex Y Doets, Hester F Lingsma, Christa Walgaard, et al.
Neurology|April 19, 2023
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Alex Y Doets, Amro Maher Stino, et al.
Pageof 41